How One Couple Navigates Uncharted Territory with GVHD After A Bone Marrow Transplant

Together, Kevin and Jaqi face graft-versus-host disease (GVHD), a complication that can occur following a bone marrow ...

How One Leukemia Survivor Navigates Life With GVHD

Graft-versus-host disease (GVHD) is a potential post-transplant complication. Here’s how one patient and his wife are ...
The Malaysian Reserve

Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)

LYMPHIR now available nationwideCRANFORD, N.J., Dec. 1, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") ...

I live with alpha-gal syndrome — a tick-borne illness that makes you allergic to meat products — and it made my life miserable

People with the allergy told The Post it has caused everything from wild, near fatal health scares to social ostracization ...

Doctor shares warning signs of 'swelling' that mean you should see a GP

Dr Aziza Sesay has explained what causes the swelling, the common symptoms, and when it ss time to see a GP for medical ...

BBC Morning Live doctor says 'common' issue could actually be cancer

Speaking about cancer, she refers to Non-Hodgkin lymphoma. The NHS noted: "The most common symptom of non-Hodgkin lymphoma is ...
Le Lézard

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

AbbVie today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including ? multiple ...
Cancer Therapy Advisor

Mogamulizumab Plus CHOP Improved PFS in Older Patients With TCL

Researchers sought to determine whether adding mogamulizumab to CHOP would improve outcomes in older patients with adult T-cell leukemia/lymphoma.